SynCardia Systems Announces Major Promotions

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

Don Webber and Peter Spadaro
Don Webber and Peter Spadaro

SynCardia Systems, LLC, manufacturer of the world’s only clinically-proven and commercially approved total artificial heart, is pleased to announce that Don Webber has been promoted to Chief Executive Officer, and Peter Spadaro has been appointed as the President and Chief Commercial Officer (CCO).

Don Webber joined SynCardia in 2018 as Chief Operating Officer (COO), leading Manufacturing Operations and Engineering, Quality and Supply Chain Logistics for the SynCardia product line. Don’s demonstrated leadership as COO led to his promotion in January 2019 to Chief Executive Officer (CEO).  He brings extensive management experience from more than 25 years in public and private sector life science companies. Prior to joining SynCardia, Don had been the COO at OptiScan since 2010. In addition, he’s previously served as VP of Manufacturing Operations at C.R. Bard, VP of Operations at EKOS Corporation, and President and CEO of Mitralign. He holds a bachelor’s degree in industrial engineering technology from the State University of New York and an MBA from Nova Southeastern University.

Peter Spadaro has joined SynCardia’s leadership team as the President and Chief Commercial Officer. Peter will be responsible for oversight of the global Sales and Marketing Organizations and for driving the company’s sales growth. He assumed the new role on April 2, 2019 reporting directly to the CEO, Don Webber.  Peter started his career at St. Jude Medical as a Sales Representative in New York City. During his almost 30-year career with St. Jude Medical he progressed through the organization’s Sales and Marketing organizations taking on leadership roles that included Vice President of Global Marketing, Vice President of Cardiovascular Sales, and Division Vice President of Cardiac Rhythm Management to name a few. Peter comes to SynCardia from his recent leadership role at Medtronic as Senior Director of Sales, Cardiac Surgery. He holds a bachelor’s degree from Fordham University.

Together, Don and Peter bring over 60 years of medical device leadership and management experience to SynCardia.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.